IP Library Assignment 016307/0406
Patent Assignment
Reel/Frame 016307/0406

Assignment of Assignor's Interest

Recorded: 2005-06-07 Pages: 4
Assignor
AMGEN SF, LLC
Executed: 2005-05-19
Assignee
AMGEN INC.
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CALIFORNIA, 91320-1799
Covered Properties (20)
Amplified cancer gene WIP1
Application: 10/073,123 →
Publication: US 2003/0032027
Amplified gene involved in cancer
Application: 10/228,263 →
Publication: US 2003/0099985
Amplified oncogenes and their involvement in cancer
Application: 10/228,264 →
Publication: US 2003/0092042
Gene amplification and overexpression in cancer
Application: 10/287,806 →
Publication: US 2003/0148341
Identification of an amplified gene and target for drug intervention
Application: 10/318,410 →
Publication: US 2003/0175763
Gene Amplification in Cancer
Patent: 6,974,672 →
Application: 10/390,191 →
Publication: US 2004/0005596
Amplification and overexpression of oncogenes
Application: 10/443,108 →
Publication: US 2004/0005615
Amplification and overexpression of oncogenes
Application: 10/623,810 →
Publication: US 2005/0059011
Amplified breast cancer gene WIP1
Application: 60/268,362 →
Amplified genes involved in cancer
Application: 60/314,655 →
Amplified genes involved in cancer
Application: 60/330,797 →
Human MKPX gene: amplification and overexpression in cancer
Application: 60/331,394 →
Amplified Galanin, GALR2 and GALR3 genes, and GALR2 and GALR3 heterocomplex, and their involvement in cancer
Application: 60/340,863 →
Identification of ACK1 as an amplified oncogene and target for drug discovery
Application: 60/341,436 →
CD24 amplification in human tumors
Application: 60/365,192 →
Amplified galanin, GALR2 and GALR3 genes, and GALR2 and GALR3 heterocomplex, and their involvement in cancer
Application: 60/375,027 →
Amplification and overexpression of recQL5, CTXL, and USP13 in human tumors
Application: 60/382,606 →
Amplification and overexpression of oncogenes
Application: 60/398,099 →
Amplification and overexpression of oncogenes
Application: 60/401,342 →
Amplification and overexpression of oncogenes
Application: 60/434,381 →
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 17, 2003
From: LI. JING; POWERS, SCOTT; YANG, JIANXIN
To: TULARIK INC.
Reel/Frame 014286/0855 →
Assignment of Assignor's Interest Sep 11, 2003
From: LI, JING; MU, DAVID; YANG, JIANXIN
To: TULARIK INC.
Reel/Frame 014487/0635 →
Assignment of Assignor's Interest Apr 21, 2004
From: SIN, WUN CHEY; YANG, JIANXIN
To: TULARIK INC.
Reel/Frame 015245/0509 →
Merger Jun 7, 2005
From: TULARIK INC.
To: ARROW ACQUISITION, LLC
Reel/Frame 016309/0003 →
Change of Name Jun 7, 2005
From: ARROW ACQUISITION, LLC
To: AMGEN SF, LLC
Reel/Frame 016309/0812 →